Anavex Life Sciences Corp (AVXL)

[wildcard235]

Excerpt from today's presentation, page 14 (emphasis added):

"AD patients with wild-type SIGMAR1 gene were found to have improved benefit from ANAVEX®2-73

"AD patients with a variant of the SIGMAR1 gene (rs1800866), were found to have a limited benefit from ANAVEX®2-73

"Majority of AD population, about 80% has no variant SIGMAR1 gene, hence the majority of patients is expected to benefit from ANAVEX®2-73"